Eccrine mixed tumor of skin

Summary

Eccrine mixed tumor of skin (MONDO:0002200) is a cancer. A subtype of eccrine sweat gland neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	eccrine mixed tumor of skin
Mondo ID	MONDO:0002200
EFO	EFO:1000385
DOID	DOID:2079
NCIT	C4474
SNOMED CT	254720009
UMLS	C0346026
MedGen	91074
Anatomy (UBERON)	UBERON:0000423
Is cancer (heuristic)	yes

Also known as: benign mixed tumor of skin · benign mixed tumor of skin (chondroid syringoma) · benign mixed tumor of the skin · benign mixed tumor of the skin (chondroid syringoma) · benign mixed tumour of skin · benign mixed tumour of skin (chondroid syringoma) · benign mixed tumour of the skin · benign mixed tumour of the skin (chondroid syringoma) · chondroid syringoma · eccrine mixed tumor (morphologic abnormality) · eccrine mixed tumour (morphologic abnormality) · eccrine sweat gland mixed neoplasm · mixed tumor of the skin (chondroid syringoma) · mixed tumour of the skin (chondroid syringoma)

Disease family

This is a subtype of eccrine sweat gland neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › skin neoplasm › epidermal appendage tumor › sweat gland neoplasm › eccrine sweat gland neoplasm › eccrine mixed tumor of skin

Related subtypes (4): eccrine papillary adenoma, eccrine sweat gland cancer, benign eccrine neoplasm, eccrine sweat gland hamartoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.